Merck KGaA Withdraws Filing for Oral MS Drug in Europe Published: Feb 18, 2011 Pharma Times -- Merck KGaA has decided to pull a submission for its new multiple sclerosis pill cladribine in Europe, after the regulator required more data. Related links News Release This will open in a new window Pharma Times [Free Reg Req'd] This will open in a new window Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news